STOCK MARKET BSE NSE

Morepen Labs starts production of test batch of Sputnik V vaccine

In total, agreements with partners in India provide for the production of more than 850 million doses of Sputnik V per year, the statement said.

Published: 06th July 2021 03:37 PM  |   Last Updated: 06th July 2021 03:37 PM   |  A+A-

The second consignment of COVID-19 vaccine Sputnik V arrives at Rajiv Gandhi International Airport in Hyderabad,

Sputnik V vaccine. (Photo | PTI)

By PTI

NEW DELHI: Morepen Laboratories has started production of the test batch of Russia's Sputnik V COVID-19 vaccine at its facility in Himachal Pradesh, Russian Direct Investment Fund (RDIF) and the domestic drug firm said in a statement on Tuesday.

The first batch will be shipped to Gamaleya Center for quality control. RDIF and Morepen Laboratories have signed a cooperation agreement in June 2021 and are actively implementing the technology transfer, it added.

"As the pandemic is yet far from over and new, more dangerous variants of coronavirus are being detected in various regions of the world, RDIF is increasing capacities for the production of Sputnik V in India, one of the key hubs," RDIF CEO Kirill Dmitriev said.

Agreement with Morepen Laboratories provides for larger amounts of Sputnik V to be available, "both for India and our partners globally to speed up the vaccination with one of the best vaccines in the world," he added.

RDIF has already reached agreements earlier with other pharmaceutical companies - Gland Pharma, Hetero Biopharma, Panacea Biotec, Stelis Biopharma and Virchow Biotech - in India for the vaccine.

In total, agreements with partners in India provide for the production of more than 850 million doses of Sputnik V per year, the statement said.

"We are delighted to partner with RDIF for the prestigious project of Sputnik V production in India," Morepen Laboratories Chairman and MD Sushil Suri said.

Sputnik V is based on a proven and well-studied platform of human adenoviral vectors and uses two different vectors for the two shots in a course of vaccination, the statement said.



Comments

Disclaimer : We respect your thoughts and views! But we need to be judicious while moderating your comments. All the comments will be moderated by the newindianexpress.com editorial. Abstain from posting comments that are obscene, defamatory or inflammatory, and do not indulge in personal attacks. Try to avoid outside hyperlinks inside the comment. Help us delete comments that do not follow these guidelines.

The views expressed in comments published on newindianexpress.com are those of the comment writers alone. They do not represent the views or opinions of newindianexpress.com or its staff, nor do they represent the views or opinions of The New Indian Express Group, or any entity of, or affiliated with, The New Indian Express Group. newindianexpress.com reserves the right to take any or all comments down at any time.

flipboard facebook twitter whatsapp